MDT

96.35

-1.24%↓

A

147.54

-0.69%↓

VEEV

235.39

-1.77%↓

HQY

86.09

-8.7%↓

PHR.US

17.1

-0.41%↓

MDT

96.35

-1.24%↓

A

147.54

-0.69%↓

VEEV

235.39

-1.77%↓

HQY

86.09

-8.7%↓

PHR.US

17.1

-0.41%↓

MDT

96.35

-1.24%↓

A

147.54

-0.69%↓

VEEV

235.39

-1.77%↓

HQY

86.09

-8.7%↓

PHR.US

17.1

-0.41%↓

MDT

96.35

-1.24%↓

A

147.54

-0.69%↓

VEEV

235.39

-1.77%↓

HQY

86.09

-8.7%↓

PHR.US

17.1

-0.41%↓

MDT

96.35

-1.24%↓

A

147.54

-0.69%↓

VEEV

235.39

-1.77%↓

HQY

86.09

-8.7%↓

PHR.US

17.1

-0.41%↓

Search

Avalo Therapeutics

Open

16.28 -3.5

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

16.15

Max

17.01

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+122.09% upside

Dividenden

By Dow Jones

Volgende Winsten

19 mrt 2026

Avalo Therapeutics Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 jan 2026, 00:16 UTC

Acquisities, Fusies, Overnames

Edwards Lifesciences Drops Merger With JenaValve

11 jan 2026, 23:46 UTC

Marktinformatie

Gold Rises Amid Geopolitical Risks -- Market Talk

11 jan 2026, 23:35 UTC

Marktinformatie

Oil Rises Amid Middle East Tensions -- Market Talk

11 jan 2026, 23:25 UTC

Winsten

Stock Futures Drift Lower With Bank Earnings, CPI on Tap -- Barrons.com

11 jan 2026, 22:05 UTC

Marktinformatie

Iron Ore Outlook Weighed by Soft China Steel Markets, Rising Supply -- Market Talk

10 jan 2026, 12:00 UTC

Acquisities, Fusies, Overnames

Copper Is the Prize in Mining Megadeals -- WSJ

10 jan 2026, 09:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

10 jan 2026, 09:20 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Basic Materials Roundup: Market Talk

10 jan 2026, 09:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

9 jan 2026, 22:18 UTC

Marktinformatie

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9 jan 2026, 21:50 UTC

Marktinformatie

Energy & Utilities Roundup: Market Talk

9 jan 2026, 21:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Basic Materials Roundup: Market Talk

9 jan 2026, 21:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

9 jan 2026, 21:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

9 jan 2026, 21:43 UTC

Winsten
Acquisities, Fusies, Overnames

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9 jan 2026, 20:39 UTC

Marktinformatie

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9 jan 2026, 20:38 UTC

Marktinformatie

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9 jan 2026, 20:36 UTC

Acquisities, Fusies, Overnames

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9 jan 2026, 20:30 UTC

Marktinformatie

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9 jan 2026, 20:15 UTC

Marktinformatie

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9 jan 2026, 20:07 UTC

Marktinformatie

Global Equities Roundup: Market Talk

9 jan 2026, 20:07 UTC

Marktinformatie

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9 jan 2026, 19:58 UTC

Acquisities, Fusies, Overnames

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9 jan 2026, 19:42 UTC

Marktinformatie

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9 jan 2026, 19:38 UTC

Acquisities, Fusies, Overnames

Wolters Kluwer Acquires StandardFusion >WTKWY

9 jan 2026, 19:31 UTC

Winsten

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9 jan 2026, 19:28 UTC

Winsten

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9 jan 2026, 18:30 UTC

Marktinformatie

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9 jan 2026, 18:23 UTC

Marktinformatie

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9 jan 2026, 17:20 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Basic Materials Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Avalo Therapeutics Prognose

Koersdoel

By TipRanks

122.09% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 38 USD  122.09%

Hoogste 48 USD

Laagste 25 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avalo Therapeutics - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Financieel

$

help-icon Live chat